Targovax TRVX Capital Markets Day February 2021

    163
    541
    Targovax TRVX Capital Markets Day February 2021

    The agenda will be as follows: Agenda & speakers 2:30-2:40 PM Welcome Øystein Soug, CEO, Targovax 2:40-3:25 PM Anti-PD1 refractory melanoma Alexander N. Shoushtari, MD 3:25-3:45 PM ONCOS-102 development program Magnus Jäderberg, CMO, Targovax 5 minutes break 3:50-4:05 PM Immune activation Victor Levitsky, CSO, Targovax 4:05-4:15 PM Preclinical pipeline update Victor Levitsky, CSO, Targovax 4:15-4:25 PM 4Q update Torbjørn Furuseth, CFO, Targovax 4:25 PM Closing remarks Øystein Soug, CEO, Targovax

    You may also like

    Page 1 of 28

    Comments are closed.